Prioritizing Genetic Contributors to Cortical Alterations in 22q11.2 Deletion Syndrome Using Imaging Transcriptomics

Cereb Cortex. 2021 Jun 10;31(7):3285-3298. doi: 10.1093/cercor/bhab008.

Abstract

22q11.2 deletion syndrome (22q11DS) results from a hemizygous deletion that typically spans 46 protein-coding genes and is associated with widespread alterations in brain morphology. The specific genetic mechanisms underlying these alterations remain unclear. In the 22q11.2 ENIGMA Working Group, we characterized cortical alterations in individuals with 22q11DS (n = 232) versus healthy individuals (n = 290) and conducted spatial convergence analyses using gene expression data from the Allen Human Brain Atlas to prioritize individual genes that may contribute to altered surface area (SA) and cortical thickness (CT) in 22q11DS. Total SA was reduced in 22q11DS (Z-score deviance = -1.04), with prominent reductions in midline posterior and lateral association regions. Mean CT was thicker in 22q11DS (Z-score deviance = +0.64), with focal thinning in a subset of regions. Regional expression of DGCR8 was robustly associated with regional severity of SA deviance in 22q11DS; AIFM3 was also associated with SA deviance. Conversely, P2RX6 was associated with CT deviance. Exploratory analysis of gene targets of microRNAs previously identified as down-regulated due to DGCR8 deficiency suggested that DGCR8 haploinsufficiency may contribute to altered corticogenesis in 22q11DS by disrupting cell cycle modulation. These findings demonstrate the utility of combining neuroanatomic and transcriptomic datasets to derive molecular insights into complex, multigene copy number variants.

Keywords: DGCR8; copy number variant; cortical thickness; gene expression; surface area.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 22q11 Deletion Syndrome / diagnostic imaging*
  • 22q11 Deletion Syndrome / genetics*
  • 22q11 Deletion Syndrome / pathology
  • Brain Cortical Thickness*
  • Case-Control Studies
  • Cerebral Cortex / diagnostic imaging*
  • Cerebral Cortex / embryology
  • Cerebral Cortex / pathology
  • DNA Copy Number Variations
  • Gene Expression Profiling
  • Gene Expression Regulation, Developmental / genetics
  • Haploinsufficiency
  • Humans
  • Magnetic Resonance Imaging
  • MicroRNAs / genetics
  • Mitochondrial Proteins / genetics
  • RNA-Binding Proteins / genetics
  • Receptors, Purinergic P2 / genetics

Substances

  • AIFM3 protein, human
  • DGCR8 protein, human
  • MicroRNAs
  • Mitochondrial Proteins
  • RNA-Binding Proteins
  • Receptors, Purinergic P2
  • purinoceptor P2X6